Di Gu

611 total citations · 1 hit paper
37 papers, 399 citations indexed

About

Di Gu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Di Gu has authored 37 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 9 papers in Rheumatology. Recurrent topics in Di Gu's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Renal cell carcinoma treatment (7 papers). Di Gu is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Renal cell carcinoma treatment (7 papers). Di Gu collaborates with scholars based in China, United States and United Kingdom. Di Gu's co-authors include Yu‐Tian Xiao, Haojie Huang, Shancheng Ren, Yundong He, Weidong Xu, Yongda Liu, Xiangkun Wu, Daojun Lv, Xiaolu Duan and Guohua Zeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Di Gu

34 papers receiving 397 citations

Hit Papers

Targeting signaling pathways in prostate cancer: mechanis... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
    2022 149 citations Yu‐Tian Xiao, Di Gu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Di Gu China 11 201 189 117 83 44 37 399
Laura N. Mutton United States 9 236 1.2× 204 1.1× 82 0.7× 90 1.1× 32 0.7× 10 380
Lucie Hamel Canada 12 181 0.9× 161 0.9× 109 0.9× 70 0.8× 24 0.5× 21 373
Jason Kirk United States 12 293 1.5× 133 0.7× 136 1.2× 123 1.5× 40 0.9× 17 491
Frank Duong United States 9 151 0.8× 108 0.6× 101 0.9× 119 1.4× 50 1.1× 14 302
Shazia Irshad United Kingdom 9 209 1.0× 124 0.7× 110 0.9× 100 1.2× 22 0.5× 12 356
Elyse L. Walk United States 8 192 1.0× 110 0.6× 101 0.9× 64 0.8× 16 0.4× 10 338
Eungbae Lee South Korea 10 178 0.9× 107 0.6× 64 0.5× 52 0.6× 24 0.5× 24 304
Xinxing Du China 8 144 0.7× 133 0.7× 132 1.1× 62 0.7× 26 0.6× 28 288
Rachel Schaefer United States 8 115 0.6× 299 1.6× 137 1.2× 88 1.1× 34 0.8× 14 382
Song-Chang Lin United States 6 151 0.8× 82 0.4× 68 0.6× 120 1.4× 23 0.5× 11 280

Countries citing papers authored by Di Gu

Since Specialization
Citations

This map shows the geographic impact of Di Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Gu more than expected).

Fields of papers citing papers by Di Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Gu. The network helps show where Di Gu may publish in the future.

Co-authorship network of co-authors of Di Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Di Gu. A scholar is included among the top collaborators of Di Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Gu. Di Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Hongyu, Di Gu, Ming Chen, et al.. (2025). Inhibition of LIMK reduces contraction and proliferation in bladder smooth muscle induced by TGF- β1. European Journal of Pharmacology. 997. 177459–177459. 1 indexed citations
2.
3.
Huang, Yueting, et al.. (2025). Learning curve analysis of extraperitoneal single-site robotic-assisted radical prostatectomy: a CUSUM-based approach. Journal of Robotic Surgery. 19(1). 49–49. 1 indexed citations
4.
Wang, Ming, Ruiqi Deng, Lei Wang, et al.. (2024). Association between 3D membranous urethral parameters and urinary continence recovery after RARP. European journal of medical research. 29(1). 165–165. 3 indexed citations
5.
Jiang, Aimin, Zi‐jun Xu, Xiao Fang, et al.. (2023). RNA modification pattern‐based subtypes reveal heterogenous clinical outcomes and tumor immunity of clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 2(1). 7 indexed citations
6.
Li, Haiyang, Zixuan Yang, Lijuan Deng, et al.. (2023). Mutation divergence over space in tumour expansion. Journal of The Royal Society Interface. 20(208). 20230542–20230542. 2 indexed citations
7.
Meng, Jialin, Aimin Jiang, Xiaofan Lu, et al.. (2023). Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. SHILAP Revista de lepidopterología. 2(4). e147–e147. 21 indexed citations
8.
He, Tao, Qiansheng Zhang, Peng Xu, et al.. (2023). Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts. Molecular Cancer. 22(1). 117–117. 36 indexed citations
9.
10.
11.
Lei, Ming, et al.. (2022). Experiences in managing different consequences of forgotten ureteral stents. Urology Annals. 14(2). 141–141. 1 indexed citations
12.
Gu, Di, et al.. (2022). PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2’-Deoxycytidine. Frontiers in Oncology. 12. 870229–870229. 3 indexed citations
13.
Tan, Wei Shen, Arjun Nathan, Nicola Pavan, et al.. (2022). Retzius-sparing technique independently predicts early recovery of urinary continence after robot-assisted radical prostatectomy. Journal of Robotic Surgery. 16(6). 1419–1426. 6 indexed citations
14.
15.
Cai, Chao, Zezhen Liu, Xiangkun Wu, et al.. (2021). Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer. Genetic Testing and Molecular Biomarkers. 25(2). 131–139. 8 indexed citations
16.
Yu, Qingfeng, Yeda Chen, Bingsheng Li, et al.. (2021). Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle. Acta Pharmaceutica Sinica B. 11(7). 1914–1930. 13 indexed citations
17.
Lv, Daojun, Xiangkun Wu, Ming Wang, et al.. (2021). Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma. Frontiers in Cell and Developmental Biology. 9. 621618–621618. 9 indexed citations
18.
Lv, Daojun, Xiangkun Wu, Xi Chen, et al.. (2021). A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy. Cancer Immunology Immunotherapy. 70(12). 3587–3602. 22 indexed citations
19.
Chen, Yeda, Di Gu, Shuxin Yang, et al.. (2020). Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments. Cancer Cell International. 20(1). 331–331. 13 indexed citations
20.
Gu, Di, et al.. (2019). One-for-All Intelligent Material for Triple-Modality Imaging-Guided Cancer Surgery. Chem. 5(11). 2742–2744. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura N. Mutton Breakdown of academic impact, for papers by Lucie Hamel Breakdown of academic impact, for papers by Jason Kirk Breakdown of academic impact, for papers by Frank Duong Breakdown of academic impact, for papers by Shazia Irshad Breakdown of academic impact, for papers by Elyse L. Walk Breakdown of academic impact, for papers by Eungbae Lee Breakdown of academic impact, for papers by Xinxing Du Breakdown of academic impact, for papers by Rachel Schaefer Breakdown of academic impact, for papers by Song-Chang Lin
Rankless by CCL
2026